UKHSA launches centralized source for infectious disease data

The UK Health Security Agency (UKHSA) has launched the first iteration of its new dashboard, which will serve as a centralized source for infectious disease and outbreak data this winter, making it publicly available in a timely and transparent way.

Few UK Alzheimer’s patients suitable for new disease-modifying drugs, study finds

Few people in the UK with early stage Alzheimer’s disease are likely to be suitable for the latest drugs which aim to halt progress of

June 12, 2024

Healthy eating social media accounts influence diet choices

Researchers from Aston University have found that people following healthy eating accounts on social media for as little as two weeks ate more fruit and

April 24, 2024

FibroGen’s pamrevlumab disappointing results marks second failure in a row – Pharmaceutical Technology

FribroGen received $150m in non-dilutive funding from Morgan Stanley Tactical Value for pamrevlumab commercialisation. Image Credit: fran_kie / Shutterstock. FibroGen’s lead candidate pamrevlumab failed to

August 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.